Yu Waye Chu
Chief Tech/Sci/R&D Officer bij CYTOMX THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Yu Waye Chu bekleedt de functie van Senior Vice President-Clinical Development bij Fate Therapeutics, Inc. Hij behaalde een bachelor aan de Princeton University en een doctoraat aan de University of Rochester School of Medicine & Dentistry.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FATE THERAPEUTICS, INC.
0.14% | 18-04-2023 | 140 676 ( 0.14% ) | 1 M $ | 31-03-2024 |
| 18-01-2024 | 26 250 ( 0.04% ) | 57 225 $ | 31-03-2024 |
Actieve functies van Yu Waye Chu
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17-07-2023 |
Eerdere bekende functies van Yu Waye Chu
| Bedrijven | Functie | Einde |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 14-07-2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-04-2019 |
Opleiding van Yu Waye Chu
| Princeton University | Undergraduate Degree |
| University of Rochester School of Medicine & Dentistry | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
